Humacyte, Inc.(HUMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HUMA Humacyte, Inc.

交易中 11-03 14:34:33 EST

0.4286

+0.0305

+7.66%

最高0.4340	最低0.3910	成交量212.42万
今开0.4048	昨收0.3981	日振幅10.80%
总市值1.19亿	流通市值1.05亿	总股本2.78亿
成交额89.75万	换手率0.87%	流通股本2.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HUMA","market":"US","secType":"STK","nameCN":"Humacyte, Inc.","latestPrice":0.4286,"timestamp":1793734463395,"preClose":0.3981,"halted":0,"volume":2124222,"delay":0,"changeRate":0.07661391610148197,"floatShares":245000000,"shares":278000000,"eps":-0.497476,"marketStatus":"交易中","change":0.0305,"latestTime":"11-03 14:34:33 EST","open":0.4048,"high":0.434,"low":0.391,"amount":897512.0471525999,"amplitude":0.108013,"askPrice":0.4313,"askSize":48,"bidPrice":0.4286,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.497476,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1793739600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3981,"preHourTrading":{"tag":"盘前","latestPrice":0.405,"preClose":0.3981,"latestTime":"09:04 EST","volume":6243,"amount":2538.41828376,"timestamp":1793714679504,"change":0.0069,"changeRate":0.017332,"amplitude":0.078372},"postHourTrading":{"tag":"盘后","latestPrice":0.4,"preClose":0.3981,"latestTime":"19:59 EST","volume":38176,"amount":15288.56414,"timestamp":1793667598088,"change":0.0019,"changeRate":0.004773,"amplitude":0.070836},"volumeRatio":0.6652,"impliedVol":1.1775,"impliedVolPercentile":0.4303},"requestUrl":"/m/hq/s/HUMA","defaultTab":"news","newsList":[{"id":"1148184945","title":"Humacyte确认与FDA沟通后计划提交Atev透析通路补充生物制剂许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1148184945","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148184945?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:05","pubTimestamp":1787573151,"startTime":"0","endTime":"0","summary":"Humacyte确认，在与美国食品药品监督管理局（FDA）进行讨论后，公司计划提交针对透析通路的Atev补充生物制剂许可申请（sBLA）。这一决定标志着公司在推进关键疗法监管审批道路上迈出了重要一步。据悉，相关申请旨在支持Atev用于透析患者血管通路建立的适应症拓展。公司方面表示，此次沟通为后续提交工作奠定了清晰路径，并有望加速该疗法的临床可及性。业内观察人士指出，这一进展或对终末期肾病患者的治疗选择产生积极影响，同时也反映了Humacyte在再生医学领域的持续深耕。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","HUMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179362309","title":"Humacyte重磅发布：V007三期血液透析通路试验结果荣登《柳叶刀-数字健康》","url":"https://stock-news.laohu8.com/highlight/detail?id=1179362309","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179362309?lang=zh_cn&edition=full","pubTime":"2026-08-19 20:01","pubTimestamp":1787140872,"startTime":"0","endTime":"0","summary":"Humacyte公司今日宣布，其V007三期血液透析通路临床试验的详细结果已正式发表于国际权威期刊《柳叶刀-数字健康》。该试验旨在评估Humacyte创新的脱细胞组织工程血管在血液透析患者血管通路建立中的安全性与有效性。Humacyte的这一进展，有望在未来重塑肾脏病治疗领域的标准实践，并推动再生医学从实验室走向更广泛的临床应用。业界普遍认为，此次学术发表或将加速该产品在全球主要市场的监管审批进程，对Humacyte的长期战略布局具有深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419278","title":"RootData：HUMA 将于一周后解锁价值约 942 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419278","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660419278?lang=zh_cn&edition=full","pubTime":"2026-08-19 11:00","pubTimestamp":1787108406,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，Huma Finance（HUMA）将于北京时间 08 月 26 日 13 时解锁约 45876 万枚代币，价值约 942 万美元。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2283677","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HUMA","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176592229","title":"Humacyte宣布FDA受理其全球首个人体临床研究申请，探索Ctev用于冠状动脉搭桥术","url":"https://stock-news.laohu8.com/highlight/detail?id=1176592229","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176592229?lang=zh_cn&edition=full","pubTime":"2026-07-27 20:03","pubTimestamp":1785153802,"startTime":"0","endTime":"0","summary":"Humacyte宣布，美国食品药品监督管理局（FDA）已正式受理其新药临床研究申请（IND），该申请旨在启动一项全球首个人体临床试验，评估其创新产品Ctev在冠状动脉搭桥术（CABG）中的应用。这一里程碑标志着Humacyte在心血管疾病治疗领域迈出关键一步，有望为患者提供更优的血管替代方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146965044","title":"Humacyte 在 V012 三期研究女性透析通路患者中期分析中，Atev 相比标准护理 AV 瘘达到主要优效性终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1146965044","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146965044?lang=zh_cn&edition=full","pubTime":"2026-06-11 04:02","pubTimestamp":1781121738,"startTime":"0","endTime":"0","summary":"在针对女性透析通路患者进行的 V012 三期临床试验中期分析中，Humacyte 的 Atev 达到了相较于标准护理动静脉（AV）瘘的主要优效性终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","HUMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636788916","title":"RootData：HUMA 将于一周后解锁价值约 1004 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2636788916","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636788916?lang=zh_cn&edition=full","pubTime":"2026-05-19 11:00","pubTimestamp":1779159606,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，Huma Finance（HUMA）将于北京时间 05 月 26 日 13 时解锁约 45876 万枚代币，价值约 1004 万美元。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2265687","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4139","HUMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634235580","title":"Huma Finance 旧版 V1 合约遭攻击，约 10.1 万美元 USDC 被盗","url":"https://stock-news.laohu8.com/highlight/detail?id=2634235580","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634235580?lang=zh_cn&edition=full","pubTime":"2026-05-11 23:46","pubTimestamp":1778514360,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Huma Finance 官方披露，其在 Polygon 上的旧版 V1 合约遭到漏洞利用，约 101,400 USDC 被转出。项目方表示，本次事件未影响用户资金安全，且 Huma Finance PST 未受影响。其在 Solana 上的 V2 系统为完全重构版本，不受该漏洞影响。Huma 方面称，团队此前已在推进 V1 流动性池逐步下线，目前已全面暂停 V1 相关合约，并将继续处理后续收尾工作。 ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2264024","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU1791807156.HKD","CRCA","CRCO","LU1861558580.USD","LU1668664300.SGD","LU1861217088.USD","CRCD","CCUP","LU1861220207.SGD","LU2360107671.USD","ICRC","CRCG","HUMA","LU0106831901.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153284815","title":"Humacyte定于2026年5月13日公布首季度财报并举行业务进展说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1153284815","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153284815?lang=zh_cn&edition=full","pubTime":"2026-05-08 20:00","pubTimestamp":1778241613,"startTime":"0","endTime":"0","summary":"再生医学公司Humacyte, Inc. 宣布，将于2026年5月13日发布其2026财年第一季度的财务业绩报告。\n届时，公司管理层将举行电话会议，不仅详细解读财报关键数据，还将同步介绍公司最新的业务进展与战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518274962","title":"Humacyte, Inc.盘中异动 急速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518274962?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:54","pubTimestamp":1741614878,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时54分，Humacyte, Inc.股票出现异动，股价急速跳水5.02%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2873.09%、639.16%、148.09%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Dogwood Therapeutics, Inc.，振幅分别为40.24%、28.59%、26.06%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215439a26a2d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215439a26a2d90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","HUMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517433197","title":"Humacyte, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517433197?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:16","pubTimestamp":1741292182,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时16分，Humacyte, Inc.股票出现异动，股价急速下跌5.08%。Humacyte, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307041622963c8819&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307041622963c8819&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HUMA","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517607531","title":"Humacyte, Inc.盘中异动 下午盘急速拉升5.07%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517607531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517607531?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:19","pubTimestamp":1741112360,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时19分，Humacyte, Inc.股票出现波动，股价大幅上涨5.07%。截至发稿，该股报3.21美元/股，成交量145.081万股，换手率1.13%，振幅7.53%。Humacyte, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305021920989be2db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305021920989be2db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HUMA","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516653237","title":"Humacyte, Inc.盘中异动 早盘股价大跌5.29%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516653237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516653237?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:18","pubTimestamp":1741018712,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时18分，Humacyte, Inc.股票出现波动，股价大幅下跌5.29%。截至发稿，该股报3.22美元/股，成交量53.2394万股，换手率0.41%，振幅7.35%。Humacyte, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001832a25d6177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001832a25d6177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HUMA","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514892763","title":"Humacyte, Inc.盘中异动 早盘大幅拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514892763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514892763?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:24","pubTimestamp":1740669850,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时24分，Humacyte, Inc.股票出现异动，股价快速拉升5.25%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272324109632bcf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272324109632bcf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","HUMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514569328","title":"Humacyte, Inc.盘中异动 早盘急速上涨15.92%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514569328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514569328?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580342,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Humacyte, Inc.股票出现波动，股价快速拉升15.92%。截至发稿，该股报3.52美元/股，成交量77.8294万股，换手率0.60%，振幅7.89%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223222abdded03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223222abdded03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HUMA","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514019069","title":"Humacyte, Inc.盘中异动 快速下跌5.28%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514019069?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:13","pubTimestamp":1740499989,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时13分，Humacyte, Inc.股票出现异动，股价大幅下挫5.28%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001309963008d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001309963008d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HUMA","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513518720","title":"Humacyte, Inc.盘中异动 大幅跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513518720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513518720?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:57","pubTimestamp":1740409047,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时57分，Humacyte, Inc.股票出现波动，股价快速下挫5.37%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225728962e9f5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225728962e9f5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","HUMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512199583","title":"Humacyte, Inc.盘中异动 急速下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512199583?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:30","pubTimestamp":1739907007,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时30分，Humacyte, Inc.股票出现波动，股价大幅下挫5.24%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219033008a24aea36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219033008a24aea36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","HUMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508014916","title":"Humacyte, Inc.盘中异动 早盘急速下挫5.24%报4.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508014916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508014916?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:31","pubTimestamp":1738593083,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分，Humacyte, Inc.股票出现异动，股价快速下挫5.24%。截至发稿，该股报4.34美元/股，成交量16.739万股，换手率0.13%，振幅1.88%。Humacyte, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223124abc10672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223124abc10672&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HUMA","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507708686","title":"Humacyte, Inc.盘中异动 下午盘股价大涨5.04%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507708686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507708686?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:05","pubTimestamp":1738267537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时05分，Humacyte, Inc.股票出现异动，股价快速上涨5.04%。截至发稿，该股报4.79美元/股，成交量85.2009万股，换手率0.66%，振幅4.28%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040537abbd854f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040537abbd854f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HUMA","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503262425","title":"Humacyte, Inc.盘中异动 股价大涨5.05%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503262425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503262425?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:41","pubTimestamp":1736959290,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时41分，Humacyte, Inc.股票出现异动，股价快速拉升5.05%。截至发稿，该股报4.33美元/股，成交量122.69万股，换手率0.95%，振幅7.28%。Humacyte, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Humacyte, Inc.公司简介：Humacyte Inc 正在开发一个颠覆性的生物技术平台，以提供可普遍植入的生物工程人体组织和器官，旨在改善患者的生活并改变医学实践。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160041309604d2d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160041309604d2d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","HUMA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.humacyte.com;investors.humacyte.com","stockEarnings":[{"period":"1week","weight":-0.0062},{"period":"1month","weight":-0.2366},{"period":"3month","weight":-0.441},{"period":"6month","weight":-0.5951},{"period":"1year","weight":-0.7616},{"period":"ytd","weight":-0.5855}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Humacyte, Inc.于2020年7月1日在特拉华州注册成立。该公司是一家处于商业化阶段的生物技术平台公司，致力于以商业规模开发可普遍植入的生物工程人体组织。其主要产品Symvess是一种经美国食品药品监督管理局批准的无细胞组织工程血管，用于肢体动脉损伤时的血管导管，公司还在开发用于其他血管及非血管应用的同类产品线。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.017034},{"month":2,"riseRate":0.833333,"avgChangeRate":0.099369},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.187537},{"month":4,"riseRate":0.666667,"avgChangeRate":0.081164},{"month":5,"riseRate":0.666667,"avgChangeRate":0.349792},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.25418},{"month":7,"riseRate":0.666667,"avgChangeRate":0.194299},{"month":8,"riseRate":0.5,"avgChangeRate":-0.018547},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.110856},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.125589},{"month":11,"riseRate":0.333333,"avgChangeRate":0.002891},{"month":12,"riseRate":0.5,"avgChangeRate":-0.123651}],"exchange":"NASDAQ","name":"Humacyte, Inc.","nameEN":"Humacyte, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Humacyte, Inc.(HUMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Humacyte, Inc.(HUMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Humacyte, Inc.,HUMA,Humacyte, Inc.股票,Humacyte, Inc.股票老虎,Humacyte, Inc.股票老虎国际,Humacyte, Inc.行情,Humacyte, Inc.股票行情,Humacyte, Inc.股价,Humacyte, Inc.股市,Humacyte, Inc.股票价格,Humacyte, Inc.股票交易,Humacyte, Inc.股票购买,Humacyte, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Humacyte, Inc.(HUMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Humacyte, Inc.(HUMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}